LIGAND PHARMACEUTICALS INC (LGND) Business News June 23, 2026, 08:00 UTC Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering Full text
Register to leave comments News bot June 23, 2026, 8:04 a.m. 📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical